Dramatic effect of levetiracetam on posthypoxic myoclonus: Difficult weaning from mechanical ventilation

Clinical Neuropharmacology

Volumn 32, Issue 4, 2009, Pages 236-

  Muslu, Bünyamin ^a   Klc, Oya ^b   Horasanl, Eyüp ^b   Dikmen, Bayazit ^b  

^a FATIH UNIVERSITY   (Turkey)

^b ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; DOPAMINE; ETIRACETAM; PIRACETAM; VALPROIC ACID;

ADULT; ARTIFICIAL VENTILATION; BRADYCARDIA; BRAIN ISCHEMIA; CASE REPORT; DRUG EFFECT; ELECTROENCEPHALOGRAM; HUMAN; HYPOTENSION; HYPOXIA; LETTER; MALE; MYOCLONUS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT TRANSPORT; PRIORITY JOURNAL; RESUSCITATION; TRANSTHORACIC ECHOCARDIOGRAPHY;

ADULT; ANTICONVULSANTS; HUMANS; HYPOXIA, BRAIN; MALE; MYOCLONUS; PIRACETAM; TREATMENT OUTCOME; VENTILATOR WEANING;

EID: 68949187961     PISSN: 03625664     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.wnf.0000265978.72772.2d     Document Type: Letter

References (4)

1. Frucht S, Fahn S. The clinical spectrum of posthypoxic myoclonus. Mov Disord 2000;15(suppl 1):2-7.
2. Hallett M. Physiology of human posthypoxic myoclonus. Mov Disord 2000;15(suppl 1):8-13.
3. Genton P, Van Vleymen B. Piracetam and levetiracetam: close structural similarities but different pharmacological and clinical profiles. Epileptic Disord 2000;2: 99-105.
4. Frucht SJ, Louis ED, Chuang C, et al. A pilot tolerability and efficacy study of levetiracetam in patients with chronic myoclonus. Neurology 2001;57(6): 1112-1114.